Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study

BACKGROUND: In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosphatemia after an equivalent dosage of FDI had not been assessed prospectively. M...

詳細記述

保存先:
書誌詳細
出版年:BMC Med
主要な著者: Emrich, I. E., Lizzi, F., Siegel, J. D., Seiler-Mussler, S., Ukena, C., Kaddu-Mulindwa, D., D’Amelio, R., Wagenpfeil, S., Brandenburg, V. M., Böhm, M., Fliser, D., Heine, G. H.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359262/
https://ncbi.nlm.nih.gov/pubmed/32654663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-020-01643-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料